Summary
Peptide YY (PYY) is a recently discovered peptide found in the distal ileum and colon. It circulates in plasma and concentrations rise in malabsorptive conditions. The potential of PYY as an indicator of impaired carbohydrate digestion was studied in a pharmacological model of intestinal glucosidase inhibition. Thirteen type-2 diabetics on long-term treatment with the alpha-glucosidase inhibitor acarbose (3 × 100 mg per day) had test meals with and without acarbose 100 mg before and after the treatment period (mean 46 weeks), a test meal with acarbose after 20 weeks of continuous treatment and a final test meal without acarbose 6 weeks after cessation of treatment. Without acarbose mean plasma PYY concentrations rose from a mean basal value of 11.5±2.9 pmol/l to 19.5±3.9 pmol/l 120 min postprandially (P<0.01). Acarbose treatment did not effect basal plasma PYY concentrations but significantly enhanced food stimulated PYY concentrations acutely, at 20 weeks and at the final treatment test meal. Mean incremental integrated plasma responses (area under curve) rose by 183%, 184% and 169%, respectively (P<0.05). After cessation of treatment postprandial responses returned to pretreatment values within 6 weeks. Conversely, the integrated incremetal postprandial plasma responses of glucose and insulin were reversibly reduced by acarbose to 58%±9% and 60%±10% of controls, respectively. Self-assesed side effects of flatulence and more frequent bowel action showed no regular relationship to the PYY response. PYY seems to act as an indicator of the increased carbohydrate load to the distal intestine even in the absence of clinical symptoms. It may contribute to the hypoglycaemic effect of alpha-glucosidase inhibitors by slowing down intestinal transit.
Similar content being viewed by others
Abbreviations
- IIR:
-
Incremental integrated response
- KIU:
-
Kallikrein inhibitory units
- PYY:
-
Peptide tyrosin-tyrosin
- TIR:
-
Total integrated response
- TM1–6:
-
Test meal 1–6
References
Adrian TE, Sagor GR, Savage AP, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR (1983) Low dose PYY inhibits gastric secretion in man. Gut 24:479A
Adrian TE, Ferri G-L, Bacarese-Hamilton AJ, Füeßl HS, Polak JM, Bloom SR (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070–1077
Adrian TE, Long RG, Füeßl HS, Bloom SR (1985) Plasma peptide YY (PYY) in the dumping syndrome. Dig Dis Sci 30:1145–1148
Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR (1985) Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89:494–499
Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman HS, Bloom SR (1986) Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 90:379–384
Adrian TE, Savage AP, Füeßl HS, Wolfe K, Besterman HS, Bloom SR (1987) Release of peptide YY (PYY) after resection of small bowel, colon or pancreas in man. Surgery 101:715–719
Albano JDM, Ekius RP, Maritz G, Turner RC (1972) A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70:487–509
Ali-Rachedi A, Verndell IM, Adrian TE, Gapp DA, Van Noorden S, Bloom SR, Polak JM (1984) Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry 80:487–491
Allen JM, Fitzpatrick ML, Yeats JC, Darcy K, Adrian TE, Bloom SR (1984) Effect of peptide YY and neuropeptide Y on gastric emptying in man. Digestion 30:255–262
Caspary WF, Graf S (1978) Inhibition of human intestinal alpha-glucose hydrolases by a new complex oligosaccharide. Res Exp Med (Berl) 175:1–6
Lundberg JM, Tatemoto K, Terenius L, Hellstrom PM, Mutt V, Hokfeldt T, Hamberger B (1982) Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA 79:4471–4475
Sachse G, Willms B (1979) Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics. Diabetologia 17:287–290
Savage AP, Adrian TE, Carolan G, Chatterjee VK, Polak JM, Bloom SR (1987) Effects of peptide YY (PYY) on mouth-caecum intestinal transit and gastric emptying. Gut 28:166–170
Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York Toronto London, pp 166–173
Stern DH, Walsh JH (1973) Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin. Gastroenterology 64:363–369
Suzuki J, Nakaya M, Itoh Z, Tatemoto K, Mutt V (1983) Inhibition of interdigestive contractile activity in the stomach by peptide YY in Heidenhain pouch dogs. Gastroenterology 85:114–121
Tatemoto K (1982) Isolation and characterisation of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic secretion. Proc Natl Acad Sci USA 79:2514–2518
Taylor RH, Jenkins DJA, Barker HM, Lee DA, Allen HB, MacDonald G (1983) Effect of acarbose on carbohydrate absorption and 24-h glycaemic profile. In: Creutzfeldt W (ed) First International Symposium on Acarbose: Effects on Carbohydrate and Fat metabolism; International Congress Series 594. Excerpta Medica, Amsterdam, pp 201–205
Uttenthal LO, Ukponmwan OO, Wood SM, Ghiglione M, Ghatei MA, Trayner IM, Bloom SR (1986) Long-term effects on intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas. Diabetic Med 3:155–160
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Zöllner on the occasion of his 65th birthday. H.S.F. was supported by Deutsche Forschungsgemeinschaft (Fu 165/1–2)
Rights and permissions
About this article
Cite this article
Füeßl, H.S., Adrian, T.E., Uttenthal, L.O. et al. Peptide YY in diabetics treated chronically with an intestinal glucosidase inhibitor. Klin Wochenschr 66, 985–989 (1988). https://doi.org/10.1007/BF01738114
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01738114